PMDD diagnostic criteria

PMDD entered the DSM-5 as a formal diagnosis in 2013, and the DSM-5-TR, published in 2022, kept the same criteria. The World Health Organization followed with ICD-11, where PMDD sits under code GA34.41, listed under conditions related to the female genital organs or menstrual cycle, not among the depressive disorders (that classification is specific to DSM-5-TR).

The DSM-5-TR criteria describe a pattern, not just a list of feelings. You need at least five of 11 symptoms present in the final week before your period, improving within a few days after it starts, and minimal or gone in the week that follows. One of the five has to be a core mood symptom: marked mood swings or rejection sensitivity, irritability or anger, low mood or hopelessness, or anxiety and tension. The symptoms also have to interfere with work, school, or relationships, and can't be fully explained by another condition.

PMS has no equivalent entry in the DSM-5. It's defined instead through clinical guidelines and descriptive ICD criteria, which cover a broader range of physical and emotional symptoms without requiring a specific mood symptom or a five-symptom minimum. That's the real difference between the two on paper. PMS is a clinical pattern described in guidelines. PMDD is a DSM diagnosis with a stricter, countable threshold.

The 11 DSM-5-TR symptoms fall into two groups. The four core mood symptoms:

• Marked mood swings or sudden tearfulness
• Marked irritability, anger, or increased conflict with others
• Markedly depressed mood, hopelessness, or self-critical thoughts
• Marked anxiety, tension, or feeling on edge

And seven additional symptoms:

• Decreased interest in usual activities
• Trouble concentrating
• Fatigue or low energy
• Changes in appetite, overeating, or food cravings
• Sleeping too much or too little
• Feeling overwhelmed or out of control
• Physical symptoms like breast tenderness, bloating, joint or muscle pain, or weight gain

You need at least five total, and at least one has to come from the first group. Five symptoms that are all physical, with no mood symptom among them, don't meet the PMDD criteria, even if they're severe. For the full list with examples of what each one can look like day to day, see PMDD symptoms: the 11 DSM-5 symptoms, explained.

A diagnosis can't rest on how you remember last month felt. Memory of premenstrual weeks tends to run worse than daily ratings show in real time, which is part of why DSM-5-TR requires prospective tracking across at least two menstrual cycles before PMDD is confirmed.

The reason for two cycles specifically shows up in how researchers test the criteria. A 2003 study in the Journal of Psychiatric Research compared different ways of applying DSM-IV thresholds to daily ratings and found that a literal, single-read threshold correctly identified only 28% of genuinely symptomatic cycles. Combining a 30% symptom-severity threshold with a 50% threshold for the symptom-free week after the period raised that to 92%, with 72% accuracy for ruling out PMDD in people without it.

A 1997 study in the Journal of Psychosomatic Obstetrics and Gynaecology that walked through all four DSM-IV research criteria in a mixed group of women found prevalence estimates ranging from 1.0% to 7.1%, depending on which method was used to measure symptom change. That spread is the practical argument for sticking with the full two-cycle protocol instead of a shortcut version. Shortcuts move the number a lot.

Premenstrual exacerbation (PME) is a different pattern from PMDD, even though the two can look similar in a bad week. PME means an existing condition, most often depression, anxiety, or something like ADHD, that's present all month but flares before your period. PMDD means the symptoms are largely absent for most of the cycle and only show up in that final week.

On paper, this matters for how a clinician reads your tracking. If your mood ratings never drop to near zero outside the luteal week, that points toward PME rather than PMDD, because PMDD's defining feature is the contrast between a largely symptom-free follicular phase and a hard luteal week. (See the luteal phase: what's happening in your body and mood for more on that timing.) Differential diagnosis guidance also lists major depression, generalized anxiety, panic disorder, and bipolar disorder as conditions to rule out before settling on PMDD, since premenstrual worsening can happen with any of them.

PME and PMDD symptoms are equally real. What changes is which treatment makes sense, since treating an underlying condition differs from treating a cyclical disorder tied to the hormone shift itself.

The Daily Record of Severity of Problems (DRSP) is the tool researchers and clinicians treat as the gold standard for confirming PMDD. It asks you to rate a set of symptoms, usually the 11 DSM-5-TR ones plus a few related items, on a simple severity scale once a day, every day, for at least two full cycles.

In practice: you note the date, rate each symptom from not-at-all to severe, and mark whether your period started that day. After two cycles, you or your doctor line the ratings up against your cycle days. A pattern that fits PMDD shows low ratings for most of the month, a clear rise in the days before bleeding, and a drop within a few days of it starting.

Shorter screening tools exist and can flag that something's worth investigating faster, but they're not a substitute for the daily version for an actual diagnosis. For a walkthrough of what to bring to that first appointment, see how to get a PMDD diagnosis.

Two cycles of honest daily notes is slow, especially on the days the ratings are highest. Niyora is a PMS and PMDD support app; its Moon feature lets you write down what happened on a hard day, see it from another angle, and calm down before you decide what to say to anyone.

Diagnosing PMDD consistently is still a work in progress, even inside research. A recent scoping review found wide variation across studies in how symptoms are defined and measured, which risk factors get assessed, and how closely each study actually follows the DRSP gold standard versus a retrospective questionnaire that's more prone to recall bias.

That variation has real consequences for numbers you'll see quoted. One study of young Turkish women found that applying older DSM-IV thresholds put 20.4% of the group in the PMDD range, while applying the tighter DSM-5 thresholds to the same group brought that down to 10.0%. Anger and irritability were the most common symptom either way, present in 97.4% of those who met the criteria.

A newer direction is digital tracking. A systematic review of 19 studies on apps, wearables, and algorithm-based tools found they can make the prospective daily tracking that diagnosis requires easier to stick with, though the review also flagged usability and ethical questions that still need answers. If you're not sure whether what you're noticing fits this pattern at all, start with PMDD (premenstrual dysphoric disorder), explained, or take the quiz to see where your symptoms land before you start a two-cycle log.